Frequent Cannabis Use Linked to Severe Seizures
A new study has identified a concerning association between frequent cannabis use and more severe seizures among people with drug-resistant epilepsy. Researchers found that patients who reported using cannabis on most days experienced more convulsive seizures and reached specialized epilepsy care considerably sooner than patients who did not use cannabis.
The findings come from researchers at Washington University School of Medicine in St. Louis, who examined medical records involving 64 adults with drug-resistant epilepsy. The study, published Sept. 28, 2026, in the journal Epilepsia, compared 22 people who reported frequent cannabis use with 42 people who reported no cannabis use.
However, researchers emphasize an important limitation: the study does not prove that cannabis causes more severe epilepsy. It was an observational study involving a relatively small group of patients, meaning the results show an association rather than a confirmed cause-and-effect relationship.
Still, the researchers say the findings are important enough to justify larger studies and closer attention to cannabis use among people living with epilepsy.
Frequent Cannabis Use Was Associated With More Severe Seizures
The researchers defined frequent cannabis use as consuming cannabis at least 20 days per month.
Among the 22 frequent users in the study, 90% experienced focal to bilateral tonic-clonic seizures, compared with 57% of the 42 nonusers. These seizures can cause a person to lose consciousness and experience powerful muscle contractions, making them among the more dangerous seizure types.
The frequent-use group also experienced more convulsive seizures overall.
According to the researchers, frequent cannabis users had more than twice as many convulsive seizures per year as nonusers. They were also taking more anti-seizure medications when they were discharged from specialized epilepsy care.
The difference was particularly notable in how quickly patients progressed to specialized treatment.
People in the frequent-use group reached an epilepsy monitoring unit an average of five years after their first seizure. For nonusers, the average interval was 18 years.
That does not mean cannabis caused the faster progression. Instead, it indicates that patients who frequently used cannabis appeared to reach a level of difficult-to-control epilepsy much sooner.
What the Researchers Actually Studied
The study focused specifically on people with drug-resistant epilepsy, rather than the general population.
Drug-resistant epilepsy generally refers to epilepsy that has not been adequately controlled after treatment with at least two appropriate anti-seizure medications. Patients with this type of epilepsy may require specialized evaluation to determine whether changes in medication, surgery or other treatments could help control their seizures.
The researchers reviewed records from patients treated between 2019 and 2024 at an epilepsy monitoring unit associated with the University of Wisconsin School of Medicine and Public Health. The investigators compared patients who reported frequent recreational cannabis use with those who did not report cannabis use.
Of the 64 patients included in the analysis, 22 reported cannabis use at least 20 days per month.
That sample is relatively small. Therefore, the findings should not automatically be applied to every person who uses cannabis or every person diagnosed with epilepsy.
The researchers themselves say larger studies are needed.
Cannabis and Epilepsy: Association Is Not Causation
One of the most important details surrounding the research is the difference between an observed association and a proven cause.
The study found that frequent cannabis users with drug-resistant epilepsy tended to have more severe seizure patterns. But because researchers examined existing medical records rather than randomly assigning people to use cannabis or not use cannabis, they cannot establish that cannabis itself produced the difference.
Other factors could contribute.
For example, people who frequently use cannabis may differ from nonusers in ways that influence epilepsy severity. Medication adherence could also play a role. Researchers noted that people who use cannabis frequently might sometimes miss doses of prescribed anti-seizure medications, potentially contributing to poorer seizure control.
The study could not fully eliminate these possibilities.
The researchers are therefore cautious about interpreting the results. Their conclusion is that the relationship deserves additional investigation rather than that cannabis has been definitively established as a cause of worsening epilepsy.
Why THC Is Receiving Attention
The researchers are particularly interested in tetrahydrocannabinol, or THC, the primary psychoactive compound in cannabis.
Cannabis contains numerous chemical compounds, and THC and cannabidiol, commonly known as CBD, can have different effects.
This distinction is especially important because there is already an FDA-approved cannabis-derived medication used for certain seizure disorders. Epidiolex contains purified cannabidiol and does not contain THC. CBD has also shown seizure-suppressing effects in certain settings.
That does not mean all cannabis products work like prescription CBD treatment.
Researchers point out that recreational cannabis products can contain substantially higher levels of THC than cannabis products available decades ago. Many modern recreational products are also relatively low in CBD.
The researchers therefore suspect that THC could potentially play a role in the association they observed. But this remains a hypothesis that requires further research rather than an established explanation for the study’s results.
Modern Cannabis Products May Be Different
The changing potency of recreational cannabis is another reason the researchers believe the issue deserves additional investigation.
The study found a potentially interesting difference between people who began using cannabis more recently and those who started using it decades earlier.
Among the patients studied, people who first reported cannabis use within the previous decade appeared to develop seizures more quickly afterward than people who began using cannabis two or more decades ago.
Researchers caution that this observation is difficult to interpret because the number of patients was small and cannabis consumption was self-reported.
Nevertheless, they believe the pattern could provide a clue for future research.
One possibility is that changes in cannabis potency could matter. Modern products can deliver substantially more THC than older products, meaning that historical comparisons based simply on whether someone used cannabis may overlook important differences in exposure.
Researchers Found an Interesting Pattern Before Seizures
Another finding caught the researchers’ attention.
For 15 frequent cannabis users in the study where the researchers could establish the timing of events, all had started using cannabis before experiencing their first seizure.
This finding makes it less likely that those individuals simply began using cannabis because they already had epilepsy and were attempting to manage their condition.
However, it still does not establish that cannabis caused their seizures.
The distinction is important because timing alone cannot rule out other explanations.
The researchers also observed that the frequent cannabis users did not show some of the typical physical abnormalities often associated with severe epilepsy. Brain scans were largely normal, including a lack of the hippocampal scarring sometimes seen in difficult cases.
The finding has prompted researchers to consider whether cannabis-related effects on brain circuitry could potentially be involved. THC acts on receptors that are particularly concentrated in brain regions involved in seizure activity.
That possibility remains speculative and will require considerably more evidence.
Why the Findings Do Not Mean Cannabis Causes Epilepsy
The new research should not be interpreted as evidence that cannabis causes epilepsy in otherwise healthy people.
The study did not investigate the general population. It specifically examined adults who already had drug-resistant epilepsy and were receiving specialized medical care.
That distinction changes how the results should be understood.
The research asks whether frequent cannabis use is associated with seizure burden and disease progression among people with difficult-to-treat epilepsy. It does not establish whether cannabis causes epilepsy in people who do not have the condition.
It also does not establish that every person with epilepsy who uses cannabis will experience worsening seizures.
Instead, the researchers identified a pattern that warrants further study.
That caution is reflected in comments from lead author Santiago Philibert-Rosas. He said that researchers currently cannot give patients a definitive answer about whether cannabis use is affecting their seizures and that larger studies are needed to determine how much cannabis exposure matters and whether stopping use changes outcomes.
Researchers Are Planning a Larger Study
The Washington University team is now developing a larger, multisite study.
The researchers want to include people from different parts of the United States, including areas with different histories of cannabis legalization.
They also want to gather more detailed information about cannabis consumption.
That could include how frequently people use cannabis, the age at which they began using it and the method through which they consume it.
Another important change will involve measuring cannabis exposure more objectively.
The current study relied partly on participants reporting their own cannabis use. That creates the possibility of inaccurate or incomplete information.
In the planned research, investigators hope to use objective measurements such as blood tests for THC. This could provide a clearer picture of how much cannabis or THC is actually present in a participant’s system.
A larger study could also help researchers account for other factors that may affect seizure severity.
What This Means for People With Epilepsy
For people living with epilepsy, the study raises questions rather than providing a definitive answer.
Anyone taking anti-seizure medication should not assume that recreational cannabis is equivalent to a prescription cannabinoid treatment. The compounds, doses and formulations can be very different.
The new research also should not be used as a reason for people to change prescribed medication without medical guidance.
Instead, the findings highlight the importance of discussing cannabis use openly with a healthcare professional, particularly when seizures remain difficult to control.
Researchers say cannabis use should be considered when clinicians evaluate patients with epilepsy because understanding a patient’s complete substance-use history can help doctors assess possible factors associated with seizure control.
At the same time, the study’s limitations mean doctors cannot yet determine from these results exactly how much cannabis use would increase seizure risk for an individual patient.
The Bigger Question About Cannabis and Brain Health
The findings add to a growing scientific discussion about how high-THC cannabis products may affect the brain.
Cannabis research has become more complicated as legalization has expanded and products have changed.
A simple label such as “cannabis user” does not describe the amount of THC consumed, the frequency of use, the method of consumption or the concentration of the product.
Those variables can matter when researchers attempt to understand potential health effects.
The new epilepsy study demonstrates why researchers are increasingly interested in these distinctions.
The 64-person study cannot answer every question. But it provides a specific signal that frequent cannabis use and severe seizure burden may be connected in some people with drug-resistant epilepsy.
The next generation of research will need to determine whether that connection remains after accounting for other risk factors and, most importantly, whether cannabis exposure actually contributes to worsening seizure control.
More Questions Than Answers
The new research provides a reason for caution but not a final verdict on cannabis and epilepsy.
Frequent cannabis use was associated with more severe convulsive seizures, greater seizure burden and a faster progression to specialized care among the drug-resistant epilepsy patients studied. Frequent users also appeared to reach medication-resistant disease much sooner than nonusers.
Yet researchers stress that the study was observational, involved only 64 people and relied partly on self-reported cannabis use.
Those limitations are significant.
The findings therefore do not prove that cannabis causes severe seizures, nor do they establish that every person with epilepsy who uses cannabis will experience worse outcomes.
Instead, the research identifies a relationship that scientists believe deserves much closer examination.
Future studies with larger populations, objective measurements of THC exposure and more detailed information about cannabis products could provide a clearer answer.
For now, the researchers’ message is deliberately cautious: there is an association worth taking seriously, but there is not yet enough evidence to determine exactly what causes it or whether reducing cannabis use would improve seizure control.
As cannabis products continue to evolve and THC concentrations remain an important area of research, understanding their potential effects on people with epilepsy could become increasingly important.
